Palvella Therapeutics, Inc. (PVLA)
151.03
-3.29
(-2.13%)
USD |
NASDAQ |
Sep 18, 13:48
Palvella Therapeutics Price to Book Value : 10.03 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 17, 2026 | 10.24 |
| September 16, 2026 | 10.05 |
| September 15, 2026 | 10.04 |
| September 14, 2026 | 10.07 |
| September 11, 2026 | 9.966 |
| September 10, 2026 | 9.983 |
| September 09, 2026 | 10.05 |
| September 08, 2026 | 10.11 |
| September 04, 2026 | 10.44 |
| September 03, 2026 | 10.32 |
| September 02, 2026 | 10.15 |
| September 01, 2026 | 9.994 |
| August 31, 2026 | 10.13 |
| August 28, 2026 | 9.955 |
| August 27, 2026 | 9.979 |
| August 26, 2026 | 10.24 |
| August 25, 2026 | 9.840 |
| August 24, 2026 | 9.675 |
| August 21, 2026 | 9.429 |
| August 20, 2026 | 9.464 |
| August 19, 2026 | 9.954 |
| August 18, 2026 | 9.985 |
| August 17, 2026 | 10.19 |
| August 14, 2026 | 10.36 |
| August 13, 2026 | 10.39 |
| Date | Value |
|---|---|
| August 12, 2026 | 10.29 |
| August 11, 2026 | 10.24 |
| August 10, 2026 | 10.10 |
| August 07, 2026 | 10.47 |
| August 06, 2026 | 10.28 |
| August 05, 2026 | 10.28 |
| August 04, 2026 | 10.09 |
| August 03, 2026 | 9.345 |
| July 31, 2026 | 9.230 |
| July 30, 2026 | 9.970 |
| July 29, 2026 | 9.466 |
| July 28, 2026 | 9.482 |
| July 27, 2026 | 9.411 |
| July 24, 2026 | 9.161 |
| July 23, 2026 | 9.506 |
| July 22, 2026 | 9.438 |
| July 21, 2026 | 9.555 |
| July 20, 2026 | 8.241 |
| July 17, 2026 | 10.44 |
| July 16, 2026 | 9.809 |
| July 15, 2026 | 10.09 |
| July 14, 2026 | 9.936 |
| July 13, 2026 | 9.694 |
| July 10, 2026 | 9.609 |
| July 09, 2026 | 10.03 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.71 |
| Anika Therapeutics, Inc. | 2.021 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.559 |
Price to Book Value Related Metrics
| Price | 151.03 |
| Earnings Yield | -3.20% |
| Market Cap | 2.174B |